|
SuperFluids™
CFI
SuperFluids™
CFI technology works by first permeating and inflating the
pathogen particles with a selected SuperFluid™.
SuperFluids™ [SFS] are gases, such as carbon
dioxide and nitrous oxide which, when compressed exhibit enhanced
thermodynamic properties of penetration, solvation and expansion.
The overfilled particles are then decompressed, the dense-phase
fluid rapidly changes into a gaseous state rupturing the pathogen
particles at their weakest points – very much like the
embolic disruption of the ear drums of a scuba diver who surfaces
too rapidly – and becomes inactive. The now gaseous
SuperFluids™ leave the protein-rich substrate with no
toxic residuals to be removed.
SFS-CFI thus has the ability to physically disrupt and inactivate
pathogen particles, explaining its ability to inactivate nonenveloped
viruses such as polio, and a variety of other tough microorganisms
such as yeast and other Gram-positive microorganisms. SFS-CFI
also inactivates enveloped viruses, such as HIV and influenza,
by a partial phospholipid solubilization/liberation mechanism.
SFS-CFI of enveloped viruses such as MuLV, VSV, TGE, BVD,
Sindbis and HIV, and non-enveloped viruses such as Hepatitis
A, Polio, Adeno, Reo, EMC and Parvovirus B19 has been demonstrated.
In summary, SFS-CFI:
-
Disrupts and inactivates bacterial pathogens
-
Inactivates both enveloped & non-enveloped viruses
-
Employs no chemicals and non-toxic solvents
-
Rapid technique (> 6 logs in less than 20 seconds for
some viruses)
-
Low temperatures (10 to 50°C)
-
Competitive processing costs
-
Applicable to liquids and solids
-
Scalable and amenable to continuous operation
SFS-CFI
can inactivate a broad range of enveloped and non-enveloped
viruses, as much as 6 logs (1 million particles per milliliter)
in less than 20 seconds. Increasing the number of stages,
like a distillation column, increases inactivation levels.
Volumetric throughput is increased by increasing cross-sectional
area.
This
technology does not damage proteins and enzymes since it is
purely physical and does not involve the use of chemicals,
heat or irradiation. A key feature of this technology is that
proteins and enzymes are negligibly impacted and remain biologically
active. Based on purely physical principles, SFS-CFI does
not rely on potentially toxic organic solvents, DNA/RNA modifying
chemicals, denaturing heat or irradiation techniques.
SFS-CFI is a closed system, fluid-liquid/solid
contacting technique that is readily scalable and amenable
to batch or continuous flow operations.
Home
l Company | Infectious
Diseases | Oncology | Nutraceuticals
| Product Pipeline | Purchase
Products | Technology Platforms
| Equipment |Patents
| Press
Releases | Contact Aphios
©1999-
2007 Aphios® Corporation
All rights reserved
|